• About
  • Subscribe
  • Advertise
  • Contact
Thursday, July 23, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

Specsavers 10 years on: Still changing the face of optometry

by Staff Writer
January 3, 2018
in Company updates & acquisitions
Reading Time: 4 mins read
A A
Share on FacebookShare on Twitter

In the 10 years since opening its first Australian store, Specsavers has grown into the country’s largest optical chain, with annual revenues approaching $1 billion.The speed of this transformation has left an indelible mark on our optometric sector and even surprised Specsavers co-founder Doug Perkins, who rbers a time when the local support team comprised of just four mbers based out of an office in Port Melbourne.“Our mission in those first few years was to ‘change the face of optometry’ and 10 years on it is rarkable to see the results,” Perkins says.{{quote-A:R-W:450-I:2-Q: We have a lofty but attainable goal – to transform eye health in Australia, New Zealand and beyond. -WHO:Doug Perkins, Co-founder of Specsavers}}“Specsavers is at its very core a partnership, and the unstinting hard work of Specsavers store partners in every state and territory, every town and local community has made possible the success to date.“We could never have imagined the pace and scale of growth that our store partners have sustained.”While some companies prefer to enter new markets by just dipping their toe in to feel the water, Specsavers made a splash. In what could possibly be the fastest practice rollout ever seen in Australia, the company opened 100 stores in its first 100 days, and ended the year with 150 locations nationwide.The first 100 stores were comprised of independent practices that were converted, at the cost of around $200,000 each, with Specsavers branding, products, systs and marketing. In the ensuing nine years, an additional 224 stores have opened, mostly on ‘greenfield’ sites that have been specifically developed from the ground up.{{image3-a:r-w:400}}During this time, both Doug and his wife Mary were personally involved with the entry into the Australian and New Zealand markets. Mary would regularly travel halfway around the world between the UK and Australia, while Doug based himself permanently in Port Melbourne from 2007–12 to oversee the expansion.“It ses quite extraordinary that 10 years have passed since we opened the first Specsavers practices in Australia,” Perkins says while conceding he could not have imagined the subsequent pace and scale of the growth that followed.“Along the way we have grown our network to 324 joint venture partnership practices and propelled hundreds of optometrists and dispensers into business for thselves, most for the first time.”It’s difficult to quantify the effect this has had on the optometric landscape in Australia, but there are some key metrics that indicate just how much of a disruptive force Specsavers has been on the market.Since its arrival on Australian shores, market researcher IBISWorld estimates the optical market has more than trebled, from slightly less than $900 million in 2007 to a forecast $3.2 billion in 2018. However, while the market has grown, so has Specsavers’ position in it.From a base of zero at the end of 2007, it’s believed Specsavers now controls approximately 40% of the market – over the previous 12 months, it has facilitated almost 40% of all eye tests performed in Australia (3,297,247), dispensed more than 40% of all prescription glasses (4,306,000 pairs), and prescribed slightly less than 40% of contact lenses (7,326,212 pairs).{{image4-a:r-w:200}}{{image5-a:r-w:200}}The growth in sales and market share can in part be attributed to Specsavers’ investment in marketing, which heralded another dramatic shift in the way optometry was performed and promoted in Australia.In 2006, the Access Economics Optometry Report found total marketing spend for the entire optometry market was $6 million. Three years later, and one year after the initial rollout, Specsavers doubled that figure with a preliminary $12 million investment to solidify and expand its foothold.It now spends more than $50 million annually on marketing and promotions, with 6.5% of every sale invested by Specsavers franchise partners into the next round of marketing. Such dominance has led to concern, especially from independent optometrists, about the future of the sector in Australia, but Perkins, predictably, sees it from a different perspective.“The dand for clinical service is at all-time high and graduate optometrists are now the most highly paid graduates in Australia, pointing to significant undersupply. In 2008 Australians were typically returning for an eye test every five years – in Specsavers stores we know that is now every 2.2 years,” he says.{{image6-a:r-w:400}}“The average price of a pair of glasses has rained almost 50% lower than 2007 prices, the optometry market has trebled in size and Australians have more choice and better value than ever before.”Crucially, it does not look like Specsavers will be slowing down in Australia any time soon. Over the past five years, Specsavers has averaged 17.07% annual growth, culminating in $947 million in revenue over the past 12 months and putting it within reach of the $1 billion mark.So, given the success of Specsavers during its first decade in Australia, the only question that rains is – ‘what about the next 10 years?’According to Perkins, the answer is simple.“We have a lofty but attainable goal – to transform eye health in Australia, New Zealand and beyond.”Whatever form that transformation takes, based on previous history it will likely happen quickly.

Related Posts

Two large companies are combining to develop an adjustable presbyopia-correcting IOL. Image: bennnn/stock.adobe.com.

Alcon, RxSight collaborating on adjustable IOL for presbyopia

by staff writer
July 17, 2026

Alcon, a global leader in eyecare, and RxSight, an ophthalmic medical device company providing high-quality customised vision to patients following...

CooperVision said new APAC president Muru Annamalai was an experienced global healthcare leader. Image: CooperVision.

CooperVision names Muru Annamalai as APAC president

by Helen Carter
July 8, 2026

CooperVision has named Muru Annamalai as president, Asia-Pacific, stating the experienced global healthcare leader will guide growth across the region....

From left, Kimberley Forbes, Raj Sundarjee, Claire Page and Tom Byrnes. Images: Specsavers.

Specsavers marks 50th Pathway Program intake of future optometry and retail partners

by Helen Carter
July 7, 2026

Specsavers has reached a key milestone in its commitment to growing future partners, celebrating the 50th intake of its store...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited